A COMPARISON OF MASKING EFFECTS OF HALOPERIDOL VERSUS MOLINDONE IN TARDIVE-DYSKINESIA

被引:17
作者
GLAZER, WM [1 ]
HAFEZ, H [1 ]
机构
[1] NASHUA BROOKSIDE HOSP,NASHUA,NH 03063
关键词
Haloperidol; Molindone; Neuroleptic; Tardive dyskinesia;
D O I
10.1016/0920-9964(90)90016-Z
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
An experimental method was utilized to compare the masking effects of two neuroleptic agents-molindone and haloperidol-on 18 neuroleptic-treated schizophrenic patients exhibiting operationally defined withdrawal-exacerbated tardive dyskinesia. After a week on one of these two medications at preestablished doses equivalent to that of the pre-study neuroleptic, molindone-masked total AIMS scores by significantly less (12%) than haloperidol (27%). Similarly, during a second week when the dose of these neuroleptics was equivalent to 200% that of the pre-study dose, molindone masked the total AIMS score significantly less (23%) as compared to haloperidol (53%). Several interpretations of this findings are considered. This study demonstrates the feasibility of a method that may offer a model for understanding pharmacological differences among neuroleptic medications. © 1990.
引用
收藏
页码:315 / 320
页数:6
相关论文
共 24 条
[1]  
ALANDER T, 1980, J PHARM PHARMACOL, V32, P780
[2]  
BALDESSARINI RJ, 1985, ANTIPSYCHOTIC AGENTS, P14
[3]  
BORISON RL, 1987, PSYCHOPHARMACOL BULL, V23, P218
[4]  
BUNNEY BS, 1975, PSYCHOPHARMACOL COMM, V1, P349
[5]  
ENDICOTT J, 1978, ARCH GEN PSYCHIAT, V35, P837
[6]   MOLINDONE - HIGHER DOSES NEEDED TO BLOCK PERGOLIDE-INDUCED ELEVATION OF SERUM CORTICOSTERONE THAN TO ELEVATE DOPAMINE METABOLITES IN BRAIN [J].
FULLER, RW ;
SNODDY, HD .
LIFE SCIENCES, 1983, 33 (23) :2357-2361
[7]   TARDIVE-DYSKINESIA DURING AND FOLLOWING TREATMENT WITH HALOPERIDOL, HALOPERIDOL + BIPERIDEN, THIORIDAZINE, AND CLOZAPINE [J].
GERLACH, J ;
SIMMELSGAARD, H .
PSYCHOPHARMACOLOGY, 1978, 59 (02) :105-112
[8]  
GLAZER W, 1981, HOSP COMMUNITY PSYCH, V32, P572
[9]   NORADRENERGIC FUNCTION AND TARDIVE-DYSKINESIA [J].
GLAZER, WM .
PSYCHIATRIC ANNALS, 1989, 19 (06) :297-301
[10]  
GLAZER WM, 1985, J CLIN PSYCHIAT, V46, P4